Comparative probiotic strain efficacy in the prevention of eczema in infants and children: A systematic review and meta-analysis

Military Medicine

Volumn 179, Issue 6, 2014, Pages 580-592

  Mansfield, Joseph A ^a   Bergin, Samuel W ^a   Cooper, James R ^a   Olsen, Cara H ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM; CHILD; COMPARATIVE STUDY; DERMATITIS, ATOPIC; DIET SUPPLEMENTATION; ECZEMA; FETAL THERAPY; HUMAN; INFANT; LACTOBACILLUS; META ANALYSIS; MICROBIOLOGY; NEWBORN; NOMENCLATURE; PRESCHOOL CHILD;

BIFIDOBACTERIUM; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIETARY SUPPLEMENTS; ECZEMA; FETAL THERAPIES; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS; PROBIOTICS; TERMINOLOGY AS TOPIC;

EID: 84919636961     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-13-00546     Document Type: Article

References (56)

1. Thomas DW, Greer FR, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition: Probiotics and prebiotics in pediatrics. Pediatrics 2010; 126: 1217-31.
2. Kawicka A, Regulska-Ilow B: How nutritional status, diet and dietary supplements can affect autism. A review. Rocz Panstw Zakl Hig 2013; 64: 1-12.
3. Williams GJ, Craig JC, Carapetis JR: Preventing urinary tract infections in early childhood. Adv Exp Med Biol 2013; 764: 211-8.
4. Kim BS, Jeon YS, Chun J: Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 71-9.
5. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI: The human microbiome project. Nature 2007; 449: 804-10.
6. Ballal SA, Gallini CA, Segata N, Huttenhower C, Garrett WS: Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts. Cell Microbiol 2011; 13: 508-17.
7. Human Microbiome Project Consortium: Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
8. Caporaso JG, Lauber CL, Costello EK, et al: Moving pictures of the human microbiome. Genome Biol 2011; 12: R50.
9. Cilieborg MS, Boye M, Sangild PT: Bacterial colonization and gut development in preterm neonates. Early Hum Dev 2012; 88(Suppl 1): S41-9.
10. Madan JC, Farzan SF, Hibberd PL, Karagas MR: Normal neonatal microbiome variation in relation to environmental factors, infection and allergy. Curr Opin Pediatr 2012; 24: 753-9.
11. Sharp RR, Achkar J-P, Brinich MA, Farell RM: Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol 2009; 104: 809-13.
12. Bonsante F, Iacobelli S, Gouyon JB: Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 2013; 30: 41-6.
13. Abrahamsson TR, Jakobsson T, Bottcher MF, et al: Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1174-80.
14. Seymour JL, Keswick BH, Hanifin JM, Jordan WP, Milligan MC: Clinical effects of diaper types on the skin of normal infants and infants with atopic dermatitis. J Am Acad Dermatol 1987; 17: 988-97.
15. Abrahamsson TR, Jakobsson T, Bjorksten B, Oldaeus G, Jenmalm MC: No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24: 556-61.
16. Hanifin JM: Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92: 44-7.
17. Abrahamsson TR, Sandberg Abelius M, Forsberg A, Björkstén B, Jenmalm MC: A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy 2011; 41: 1729-39.
18. Bottcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Björkstén B: Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 2008; 19: 497-504.
19. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-9.
20. Harrigan E, Rabinowitz L: Atopic dermatitis. Immunol Allergy Clin North Am 1999: 383-96.
21. Kalliomaki M, Salminen S, Poussa T, Isolauri E: Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-21.
22. Rautava S, Kalliomäki M, Isolauri E: Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002; 109: 119-21.
23. Kukkonen K, Savilahti E, Haahtela T, et al: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 192-8.
24. Williams HC, Burney PG, Pembroke AC, Hay RJ: The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131: 406-16.
25. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
26. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al: Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123: 335-41.
27. Kukkonen AK, Kuitunen M, Savilahti E, Pelkonen A, Malmberg P, Mäkelä M: Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol 2011; 22: 249-51.
28. Marschan E, Kuitunen M, Kukkonen K, et al: Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38: 611-8.
29. Johansson SG, Bieber T, Dahl R, et al: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-6.
30. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-91.
31. Jensen MP, Meldrum S, Taylor AL, Dunstan JA, Prescott SL: Early probiotic supplementation for allergy prevention: long-term outcomes. J Allergy Clin Immunol 2012; 130: 1209-11. e5.
32. Wickens K, Black P, Stanley TV, et al: A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42: 1071-9.
33. Williams H: So How Do I Define Atopic Eczema? A Practical Manual for Researchers Wishing to Define Atopic Eczema, 1996. Available at http://www.nottingham.ac.uk/dermatology/eczema/contents.html; accessed August 8, 2008.
34. ASCIA Skin Prick Testing Working Party: Skin prick testing for the diagnosis of allergic disease. A Manual for Practitioners, 2009. Available at http://www.allergy.org.au/images/stories/ascia_spt_manual_2009.pdf; accessed June 14, 2008.
35. Wickens K, Black PN, Stanley TV, et al: A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 788-94.
36. Allen SJ, Jordan S, Storey M, et al: Probiotics and atopic ECZEMA: a double-blind randomised controlled trial. Arch Dis Child 2012; 97: A2.
37. Boyle RJ, Ismail IH, Kivivuori S, et al: Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011; 66: 509-16.
38. Dotterud CK, Storro O, Johnsen R, Oien T: Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-23.
39. Kim JY, Kwon JH, Ahn SH, et al: Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010; 21: e386-93.
40. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121: e850-6.
41. Niers L, Martin R, Rijkers G, et al: The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64: 1349-58.
42. Rautava S, Kainonen E, Salminen S, Isolauri E: Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130: 1355-60.
43. Hanifin JM: Atopic dermatitis in infants and children. Pediatr Clin North Am 1991; 38: 763-89.
44. Roze JC, Barbarot S, Butel MJ, et al: An (alpha)-lactalbumin-enriched and symbiotic-supplemented v. a standard infant formula: a multicentre, double-blind, randomised trial. Br J Nutr 2012; 107: 1616-22.
45. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-96.
46. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E: Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008; 38: 1342-8.
47. Soh SE, Aw M, Gerez I, et al: Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-8.
48. West CE, Hammarstrom ML, Hernell O: Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20: 430-7.
49. Bohme M, Lannero E, Wickman M, Nordvall SL, Wahlgreen CF: Atopic dermatitis and concomitant disease patterns in children up to two years of age. Acta Derm Venereol 2002; 82: 98-103.
50. Kull I, Wickman M, Lilja G, Nordvall SL, Pershagen G: Breast feeding and allergic diseases in infants-a prospective birth cohort study. Arch Dis Child 2002; 87: 478-81.
51. Higgins JPT, Green S: Front matter. In: Cochrane Handbook for Systematic Reviews of Interventions, pp i-xxi. Chichester, UK, John Wiley & Sons, 2008.
52. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JA: Metan: fixed-and random-effects meta-analysis. Stata J 2008; 8: 3-28.
53. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
54. Harbord RM, Egger M, Sterne JA: A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006; 25: 3443-57.
55. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676-80.
56. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E: Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-71.